Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
SELDI-TOF-MS developed to detect biomarkers for early diagnosis of breast cancer
October 20th, 2005
SELDI-TOF-MS was developed to detect biomarkers for the early diagnosis of breast cancer. "Breast cancer has never had any good serum tumor markers. Therefore, we developed and evaluated a proteomics approach to searching for new biomarkers and building diagnostic models," scientists in People's Republic Of China report. "SELDI-TOF-MS ProteinChip was used to detect the serum protein patterns of 49 breast cancer patients, 51 patients with benign breast diseases, and 33 healthy women," wrote Y. Hu and colleagues, Zhejiang University. "The diagnostic models were developed and validated using bioinformatics tools such as artificial neural networks and...
Source: Women's Health Weekly (2005-10-20)
|
